Project Details
| Status | Active |
|---|---|
| Effective start/end date | 12/06/25 → 28/02/27 |
Clinical Trial Phase
- Phase III (a & b)
A Phase 3, Randomized, Open-Label, Multicenter Study to Compare the Efficacy and Safety of Arlocabtagene Autoleucel (BMS-986393), a GPRC5D-directed CAR-T Cell Therapy, Versus Standard Regimens in Adult Participants with Relapsed or Refractory and Lenalidomide-exposed Multiple Myeloma (QUINTESSENTIAL-2)
- Oh, Danielle (Primary Chief Investigator (PCI))
Project: Research